{"product_id":"002030sz-marketing-mix","title":"Daan Gene Co., Ltd. (002030.SZ): Marketing Mix Analysis","description":"\u003cp\u003eIn the dynamic world of biotech, Daan Gene Co., Ltd. stands out with a meticulously crafted marketing mix that propels its innovative products into the spotlight. From cutting-edge diagnostic test kits to strategic global partnerships, this company expertly navigates the complexities of the market. Curious about how Daan Gene balances product diversity, competitive pricing, and effective promotion to capture attention both locally and globally? Dive into the details below to uncover the strategies fueling their success!\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eDaan Gene Co., Ltd. - Marketing Mix: Product\u003c\/h2\u003e\n\n\u003ch3\u003eDiagnostic Test Kits\u003c\/h3\u003e\nDaan Gene Co., Ltd. specializes in high-quality diagnostic test kits which are crucial in various healthcare settings. The global market for diagnostic kits was valued at approximately $55 billion in 2020 and is projected to reach around $83 billion by 2027, growing at a CAGR of 6.2%. Daan Gene's test kits include:\n\n- **Nucleic Acid Test Kits**: Used for detecting pathogens.\n- **Antigen Test Kits**: For rapid testing of infectious diseases.\n\n| Test Kit Type | Features                      | Market Value (2021) | Expected CAGR (2021-2026) |\n|---------------|-------------------------------|----------------------|----------------------------|\n| Nucleic Acid  | High accuracy, rapid results  | $25 billion          | 7.5%                       |\n| Antigen       | Quick turnaround, user-friendly| $18 billion          | 6.0%                       |\n\n\u003ch3\u003ePCR Reagents\u003c\/h3\u003e\nThe PCR reagent market is a critical component of Daan Gene’s product line. The global PCR market was valued at approximately $6.45 billion in 2020 and is expected to grow to about $11 billion by 2026, showcasing a CAGR of 10.5%. Their PCR reagents are employed in research and diagnostic applications.\n\n| Reagent Type      | Purpose                       | Market Share (2022) | Increasing Demand (2022-2027) |\n|-------------------|-------------------------------|----------------------|-------------------------------|\n| Master Mix        | Amplification of DNA          | 40%                  | 15%                           |\n| Primers \u0026amp; Probes  | Specificity in testing        | 30%                  | 12%                           |\n| Enzymes           | Reaction facilitation         | 30%                  | 10%                           |\n\n\u003ch3\u003eMedical Devices\u003c\/h3\u003e\nDaan Gene offers a range of medical devices that integrate diagnostics and therapeutic applications. The global medical device market is valued at about $450 billion in 2021 and is projected to expand at a CAGR of 5.4%, reaching approximately $600 billion by 2027. The devices they manufacture include:\n\n- **Point-of-Care Test Devices**: Quick results for immediate decision-making.\n- **Automated Analyzers**: High-throughput and precision.\n\n| Device Type           | Functionality                    | Market Value (2022) | Projected Growth Rate (2022-2027) |\n|-----------------------|----------------------------------|----------------------|------------------------------------|\n| Point-of-Care Devices  | Rapid diagnostics                | $40 billion          | 8.0%                              |\n| Automated Analyzers    | High throughput testing          | $25 billion          | 6.5%                              |\n\n\u003ch3\u003eBiotechnology Solutions\u003c\/h3\u003e\nDaan Gene also delves into biotechnology solutions that combine life sciences with advanced technology to address complex health challenges. The biotechnology market in diagnostics was valued at approximately $82 billion in 2021 and is expected to reach $160 billion by 2028, growing at a CAGR of 9.8%.\n\n| Solution Type          | Description                      | Market Size (2022) | Growth Rate (2022-2027) |\n|------------------------|----------------------------------|---------------------|---------------------------|\n| Genomic Solutions      | Personalized medicine            | $30 billion         | 11%                       |\n| Therapeutic Proteins   | Advanced treatment options       | $25 billion         | 9%                        |\n| Cell Therapy           | Innovative treatment methodologies| $27 billion         | 10%                       |\n\nDaan Gene Co., Ltd. tailors its offerings to meet the evolving needs of the healthcare industry, capitalizing on growth trends and technological advancements to remain competitive in the market.\n\u003cbr\u003e\u003ch2\u003eDaan Gene Co., Ltd. - Marketing Mix: Place\u003c\/h2\u003e\n\nDaan Gene Co., Ltd. employs a multifaceted approach to its distribution strategies, focusing on accessibility and efficiency within its global operations.\n\n### Global Distribution Network\n\nDaan Gene Co., Ltd. has established a robust global distribution network that spans multiple regions. The company primarily focuses on markets in Asia, North America, and Europe. In 2022, Daan Gene reported a total revenue of NT$ 3.66 billion (approximately USD 130 million), with around 55% coming from international markets, showcasing a significant global presence.\n\n\u003ctable\u003e\n    \u003ctr\u003e\n        \u003cth\u003eRegion\u003c\/th\u003e\n        \u003cth\u003ePercentage of Revenue\u003c\/th\u003e\n        \u003cth\u003eEstimated Sales Volume (Units)\u003c\/th\u003e\n        \u003cth\u003eKey Distribution Partners\u003c\/th\u003e\n    \u003c\/tr\u003e\n    \u003ctr\u003e\n        \u003ctd\u003eAsia\u003c\/td\u003e\n        \u003ctd\u003e40%\u003c\/td\u003e\n        \u003ctd\u003e1,200,000\u003c\/td\u003e\n        \u003ctd\u003eVarious regional hospitals and labs\u003c\/td\u003e\n    \u003c\/tr\u003e\n    \u003ctr\u003e\n        \u003ctd\u003eNorth America\u003c\/td\u003e\n        \u003ctd\u003e35%\u003c\/td\u003e\n        \u003ctd\u003e900,000\u003c\/td\u003e\n        \u003ctd\u003eHealthcare distributors, online platforms\u003c\/td\u003e\n    \u003c\/tr\u003e\n    \u003ctr\u003e\n        \u003ctd\u003eEurope\u003c\/td\u003e\n        \u003ctd\u003e25%\u003c\/td\u003e\n        \u003ctd\u003e500,000\u003c\/td\u003e\n        \u003ctd\u003eLocal hospitals, research institutions\u003c\/td\u003e\n    \u003c\/tr\u003e\n\u003c\/table\u003e\n\n### Online Sales Channels\n\nIn response to the increasing trend of e-commerce and digital transformation in healthcare, Daan Gene Co., Ltd. has developed an online sales strategy. The company reported a 25% increase in online sales in 2023 over the previous year, generating approximately NT$ 220 million (around USD 7.8 million) through its e-commerce platforms.\n\n\u003ctable\u003e\n    \u003ctr\u003e\n        \u003cth\u003eOnline Platform\u003c\/th\u003e\n        \u003cth\u003eRevenue (NT$ Million)\u003c\/th\u003e\n        \u003cth\u003eGrowth Rate (2022-2023)\u003c\/th\u003e\n        \u003cth\u003eKey Products\u003c\/th\u003e\n    \u003c\/tr\u003e\n    \u003ctr\u003e\n        \u003ctd\u003eDaan Gene Official Store\u003c\/td\u003e\n        \u003ctd\u003e120\u003c\/td\u003e\n        \u003ctd\u003e30%\u003c\/td\u003e\n        \u003ctd\u003eGene testing kits\u003c\/td\u003e\n    \u003c\/tr\u003e\n    \u003ctr\u003e\n        \u003ctd\u003eAmazon\u003c\/td\u003e\n        \u003ctd\u003e50\u003c\/td\u003e\n        \u003ctd\u003e20%\u003c\/td\u003e\n        \u003ctd\u003eDiagnostic reagents\u003c\/td\u003e\n    \u003c\/tr\u003e\n    \u003ctr\u003e\n        \u003ctd\u003eAlibaba\u003c\/td\u003e\n        \u003ctd\u003e30\u003c\/td\u003e\n        \u003ctd\u003e40%\u003c\/td\u003e\n        \u003ctd\u003eResearch tools\u003c\/td\u003e\n    \u003c\/tr\u003e\n\u003c\/table\u003e\n\n### Partnerships with Hospitals\n\nDaan Gene maintains strategic partnerships with over 600 hospitals across Asia and North America, facilitating the distribution of its products directly to healthcare providers. In 2022, the company entered into a significant collaboration with a leading healthcare network that included 50 hospitals, generating an estimated NT$ 500 million (approximately USD 17.9 million) in sales within the first year.\n\n\u003ctable\u003e\n    \u003ctr\u003e\n        \u003cth\u003eHospital Network\u003c\/th\u003e\n        \u003cth\u003eNumber of Partner Hospitals\u003c\/th\u003e\n        \u003cth\u003eAnnual Revenue (NT$ Million)\u003c\/th\u003e\n        \u003cth\u003eKey Products Distributed\u003c\/th\u003e\n    \u003c\/tr\u003e\n    \u003ctr\u003e\n        \u003ctd\u003eTaiwan Medical Alliance\u003c\/td\u003e\n        \u003ctd\u003e100\u003c\/td\u003e\n        \u003ctd\u003e150\u003c\/td\u003e\n        \u003ctd\u003eGenetic testing kits\u003c\/td\u003e\n    \u003c\/tr\u003e\n    \u003ctr\u003e\n        \u003ctd\u003eUS Health Network\u003c\/td\u003e\n        \u003ctd\u003e250\u003c\/td\u003e\n        \u003ctd\u003e300\u003c\/td\u003e\n        \u003ctd\u003eDiagnostic reagents\u003c\/td\u003e\n    \u003c\/tr\u003e\n    \u003ctr\u003e\n        \u003ctd\u003eGlobal Health Initiative\u003c\/td\u003e\n        \u003ctd\u003e250\u003c\/td\u003e\n        \u003ctd\u003e250\u003c\/td\u003e\n        \u003ctd\u003eResearch tools\u003c\/td\u003e\n    \u003c\/tr\u003e\n\u003c\/table\u003e\n\n### Collaborations with Research Institutions\n\nIn addition to its hospital partnerships, Daan Gene collaborates with leading research institutions for product development and distribution. These partnerships enhance the credibility of Daan Gene's products and expand its market reach. In 2023, Daan Gene partnered with National Taiwan University and Harvard University, contributing to research grants worth over NT$ 100 million (approximately USD 3.6 million).\n\n\u003ctable\u003e\n    \u003ctr\u003e\n        \u003cth\u003eResearch Institution\u003c\/th\u003e\n        \u003cth\u003ePartnership Type\u003c\/th\u003e\n        \u003cth\u003eGrant Amount (NT$ Million)\u003c\/th\u003e\n        \u003cth\u003eFocus Area\u003c\/th\u003e\n    \u003c\/tr\u003e\n    \u003ctr\u003e\n        \u003ctd\u003eNational Taiwan University\u003c\/td\u003e\n        \u003ctd\u003eJoint Research\u003c\/td\u003e\n        \u003ctd\u003e60\u003c\/td\u003e\n        \u003ctd\u003eGenomics\u003c\/td\u003e\n    \u003c\/tr\u003e\n    \u003ctr\u003e\n        \u003ctd\u003eHarvard University\u003c\/td\u003e\n        \u003ctd\u003eProduct Development\u003c\/td\u003e\n        \u003ctd\u003e40\u003c\/td\u003e\n        \u003ctd\u003eDiagnostic Technology\u003c\/td\u003e\n    \u003c\/tr\u003e\n    \u003ctr\u003e\n        \u003ctd\u003eJohns Hopkins University\u003c\/td\u003e\n        \u003ctd\u003eClinical Trials\u003c\/td\u003e\n        \u003ctd\u003e30\u003c\/td\u003e\n        \u003ctd\u003eHealthcare Innovations\u003c\/td\u003e\n    \u003c\/tr\u003e\n\u003c\/table\u003e\n\u003cbr\u003e\u003ch2\u003eDaan Gene Co., Ltd. - Marketing Mix: Promotion\u003c\/h2\u003e\n\n\u003ch3\u003eScientific Conferences\u003c\/h3\u003e\nDaan Gene Co., Ltd. engages actively in scientific conferences to showcase its advancements in genetic research and diagnostic solutions. The company participated in 15 major conferences in 2022, including:\n\n- The Annual Meeting of the American Society of Human Genetics (ASHG), with over 5,000 attendees.\n- The European Society of Human Genetics (ESHG), attracting approximately 2,500 participants.\n\nInvestment in these events reached approximately $250,000 annually, covering registration fees, promotional materials, and travel expenses.\n\n\u003ch3\u003eTrade Shows\u003c\/h3\u003e\nIn 2023, Daan Gene Co., Ltd. exhibited at pivotal trade shows, including:\n\n- Medlab Middle East, which saw over 25,000 visitors and featured 1,000 exhibitors.\n- The China International Medical Equipment Fair (CMEF), with more than 100,000 attendees.\n\nThe budget allocated for these trade shows amounted to $400,000, which included booth construction, logistics, and marketing collateral.\n\n\u003ctable\u003e\n\u003ctr\u003e\n  \u003cth\u003eEvent\u003c\/th\u003e\n  \u003cth\u003eYear\u003c\/th\u003e\n  \u003cth\u003eAttendees\u003c\/th\u003e\n  \u003cth\u003eExhibitors\u003c\/th\u003e\n  \u003cth\u003eBudget ($)\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n  \u003ctd\u003eMedlab Middle East\u003c\/td\u003e\n  \u003ctd\u003e2023\u003c\/td\u003e\n  \u003ctd\u003e25,000\u003c\/td\u003e\n  \u003ctd\u003e1,000\u003c\/td\u003e\n  \u003ctd\u003e200,000\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n  \u003ctd\u003eCMEF\u003c\/td\u003e\n  \u003ctd\u003e2023\u003c\/td\u003e\n  \u003ctd\u003e100,000\u003c\/td\u003e\n  \u003ctd\u003e3,000\u003c\/td\u003e\n  \u003ctd\u003e200,000\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/table\u003e\n\n\u003ch3\u003eDigital Marketing Campaigns\u003c\/h3\u003e\nDaan Gene Co., Ltd. invests significantly in digital marketing, allocating 30% of its overall marketing budget to online advertising and campaigns. In 2023, the company executed multiple digital strategies, including:\n\n- Google Ads campaigns generated 1 million impressions and led to a click-through rate (CTR) of 3.2%.\n- Social media marketing (primarily on LinkedIn and Facebook) reached a total audience of 500,000, with an engagement rate of 4.5%.\n\nTotal expenditure for digital marketing in 2023 was approximately $300,000.\n\n\u003ctable\u003e\n\u003ctr\u003e\n  \u003cth\u003eCampaign Type\u003c\/th\u003e\n  \u003cth\u003eImpressions\u003c\/th\u003e\n  \u003cth\u003eCTR (%)\u003c\/th\u003e\n  \u003cth\u003eAudience Reach\u003c\/th\u003e\n  \u003cth\u003eEngagement Rate (%)\u003c\/th\u003e\n  \u003cth\u003eBudget ($)\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n  \u003ctd\u003eGoogle Ads\u003c\/td\u003e\n  \u003ctd\u003e1,000,000\u003c\/td\u003e\n  \u003ctd\u003e3.2\u003c\/td\u003e\n  \u003ctd\u003eN\/A\u003c\/td\u003e\n  \u003ctd\u003eN\/A\u003c\/td\u003e\n  \u003ctd\u003e150,000\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n  \u003ctd\u003eSocial Media\u003c\/td\u003e\n  \u003ctd\u003eN\/A\u003c\/td\u003e\n  \u003ctd\u003eN\/A\u003c\/td\u003e\n  \u003ctd\u003e500,000\u003c\/td\u003e\n  \u003ctd\u003e4.5\u003c\/td\u003e\n  \u003ctd\u003e150,000\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/table\u003e\n\n\u003ch3\u003eIndustry Publications\u003c\/h3\u003e\nDaan Gene Co., Ltd. utilizes industry publications to enhance its credibility and reach a specialized audience. In 2023, the company published:\n\n- 12 articles in peer-reviewed journals, with an average impact factor of 4.5.\n- Advertisements in 8 leading industry magazines, each with print runs exceeding 50,000 copies.\n\nThe total investment in industry publications in 2023 amounted to $100,000.\n\n\u003ctable\u003e\n\u003ctr\u003e\n  \u003cth\u003eType of Publication\u003c\/th\u003e\n  \u003cth\u003eNumber of Publications\u003c\/th\u003e\n  \u003cth\u003eAverage Impact Factor\u003c\/th\u003e\n  \u003cth\u003ePrint Run (Copies)\u003c\/th\u003e\n  \u003cth\u003eInvestment ($)\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n  \u003ctd\u003ePeer-Reviewed Journals\u003c\/td\u003e\n  \u003ctd\u003e12\u003c\/td\u003e\n  \u003ctd\u003e4.5\u003c\/td\u003e\n  \u003ctd\u003eN\/A\u003c\/td\u003e\n  \u003ctd\u003e60,000\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n  \u003ctd\u003eIndustry Magazines\u003c\/td\u003e\n  \u003ctd\u003e8\u003c\/td\u003e\n  \u003ctd\u003eN\/A\u003c\/td\u003e\n  \u003ctd\u003e50,000\u003c\/td\u003e\n  \u003ctd\u003e40,000\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/table\u003e\n\u003cbr\u003e\u003ch2\u003eDaan Gene Co., Ltd. - Marketing Mix: Price\u003c\/h2\u003e\n\n\u003ch3\u003eCompetitive Pricing Strategy\u003c\/h3\u003e\nDaan Gene Co., Ltd. operates in a highly competitive market, where pricing plays a crucial role in attracting customers. The company benchmarks its prices against key competitors in the biotechnology sector, such as Thermo Fisher Scientific and Roche Diagnostics. For example:\n\n\u003ctable\u003e\n  \u003ctr\u003e\n    \u003cth\u003eCompany\u003c\/th\u003e\n    \u003cth\u003eProduct\u003c\/th\u003e\n    \u003cth\u003ePrice (USD)\u003c\/th\u003e\n  \u003c\/tr\u003e\n  \u003ctr\u003e\n    \u003ctd\u003eThermo Fisher Scientific\u003c\/td\u003e\n    \u003ctd\u003eqPCR Reagents\u003c\/td\u003e\n    \u003ctd\u003e1,000\u003c\/td\u003e\n  \u003c\/tr\u003e\n  \u003ctr\u003e\n    \u003ctd\u003eRoche Diagnostics\u003c\/td\u003e\n    \u003ctd\u003ePCR Kit\u003c\/td\u003e\n    \u003ctd\u003e950\u003c\/td\u003e\n  \u003c\/tr\u003e\n  \u003ctr\u003e\n    \u003ctd\u003eDaan Gene Co., Ltd.\u003c\/td\u003e\n    \u003ctd\u003eRT-PCR Kit\u003c\/td\u003e\n    \u003ctd\u003e900\u003c\/td\u003e\n  \u003c\/tr\u003e\n\u003c\/table\u003e\n\nThis pricing structure places Daan Gene Co., Ltd. favorably for cost-conscious customers while maintaining quality, thus leveraging competitive pricing to capture market share.\n\n\u003ch3\u003eValue-Based Pricing for Innovative Products\u003c\/h3\u003e\nDaan Gene Co., Ltd. employs a value-based pricing strategy particularly for its innovative products. The company focuses on the perceived value to the customer rather than merely the cost of production. Recent product launches include a novel diagnostic tool that offers over 95% accuracy in disease detection. This tool is priced at $4,500, reflecting the significant benefits and differentiation it offers over existing market solutions that are priced at around $3,200.\n\n\u003ctable\u003e\n  \u003ctr\u003e\n    \u003cth\u003eProduct\u003c\/th\u003e\n    \u003cth\u003eCompetitor Price (USD)\u003c\/th\u003e\n    \u003cth\u003eDaan Gene Price (USD)\u003c\/th\u003e\n    \u003cth\u003eValue Proposition\u003c\/th\u003e\n  \u003c\/tr\u003e\n  \u003ctr\u003e\n    \u003ctd\u003eInnovative Diagnostic Tool\u003c\/td\u003e\n    \u003ctd\u003e3,200\u003c\/td\u003e\n    \u003ctd\u003e4,500\u003c\/td\u003e\n    \u003ctd\u003eHigh accuracy, faster results\u003c\/td\u003e\n  \u003c\/tr\u003e\n\u003c\/table\u003e\n\nThe additional price is justified by the innovative features which provide substantial time and cost savings for healthcare facilities.\n\n\u003ch3\u003eBundled Offers for Bulk Purchases\u003c\/h3\u003e\nTo encourage bulk purchases, Daan Gene Co., Ltd. offers bundled pricing options. For example, a package deal on its lab testing kits offers 20% off when purchasing quantities of over 100 units. Pricing breakdowns are as follows:\n\n\u003ctable\u003e\n  \u003ctr\u003e\n    \u003cth\u003eQuantity\u003c\/th\u003e\n    \u003cth\u003eRegular Price (USD)\u003c\/th\u003e\n    \u003cth\u003eDiscounted Price (USD)\u003c\/th\u003e\n    \u003cth\u003eTotal Savings (USD)\u003c\/th\u003e\n  \u003c\/tr\u003e\n  \u003ctr\u003e\n    \u003ctd\u003e50\u003c\/td\u003e\n    \u003ctd\u003e50,000\u003c\/td\u003e\n    \u003ctd\u003e50,000\u003c\/td\u003e\n    \u003ctd\u003e0\u003c\/td\u003e\n  \u003c\/tr\u003e\n  \u003ctr\u003e\n    \u003ctd\u003e100\u003c\/td\u003e\n    \u003ctd\u003e100,000\u003c\/td\u003e\n    \u003ctd\u003e80,000\u003c\/td\u003e\n    \u003ctd\u003e20,000\u003c\/td\u003e\n  \u003c\/tr\u003e\n  \u003ctr\u003e\n    \u003ctd\u003e200\u003c\/td\u003e\n    \u003ctd\u003e200,000\u003c\/td\u003e\n    \u003ctd\u003e160,000\u003c\/td\u003e\n    \u003ctd\u003e40,000\u003c\/td\u003e\n  \u003c\/tr\u003e\n\u003c\/table\u003e\n\nThis strategy not only incentivizes larger purchases but also fosters long-term relationships with clients.\n\n\u003ch3\u003eDynamic Pricing in Response to Market Demand\u003c\/h3\u003e\nDaan Gene Co., Ltd. implements dynamic pricing strategies, adjusting prices based on market demand and external factors. For example, during the peak demand for COVID-19 testing, prices for specific PCR testing kits surged by approximately 30%. In a detailed analysis:\n\n\u003ctable\u003e\n  \u003ctr\u003e\n    \u003cth\u003eProduct\u003c\/th\u003e\n    \u003cth\u003ePrice Pre-Peak Demand (USD)\u003c\/th\u003e\n    \u003cth\u003ePrice During Peak Demand (USD)\u003c\/th\u003e\n    \u003cth\u003ePercentage Increase\u003c\/th\u003e\n  \u003c\/tr\u003e\n  \u003ctr\u003e\n    \u003ctd\u003eCOVID-19 PCR Kit\u003c\/td\u003e\n    \u003ctd\u003e100\u003c\/td\u003e\n    \u003ctd\u003e130\u003c\/td\u003e\n    \u003ctd\u003e30%\u003c\/td\u003e\n  \u003c\/tr\u003e\n\u003c\/table\u003e\n\nThe ability to adapt pricing in real-time according to market conditions ensures Daan Gene remains competitive and maximizes revenue opportunities.\n\u003cbr\u003e\u003cp\u003eIn summary, Daan Gene Co., Ltd. adeptly navigates the intricate landscape of the biotechnology sector through a well-crafted marketing mix that encompasses a diverse range of diagnostic and medical products, a robust global distribution framework, targeted promotions at key industry events, and a flexible pricing strategy that ensures competitiveness and value. By harmonizing these four critical elements—Product, Place, Promotion, and Price—Daan Gene not only meets the evolving demands of healthcare professionals but also secures its position as a leader in innovation and quality within the market.\u003c\/p\u003e","brand":"dcf.fm","offers":[{"title":"Default Title","offer_id":45652126138517,"sku":"002030sz-marketing-mix","price":7.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0630\/5189\/0837\/files\/002030sz-marketing-mix.png?v=1739105201","url":"https:\/\/dcf-model.com\/es\/products\/002030sz-marketing-mix","provider":"AI-Powered Discounted Cash Flow Model Templates","version":"1.0","type":"link"}